Skip to content

The Archive · A Source

A New Tool for Safety Evaluation and a Combination of Measures for Efficacy Assessment of Cotransplanting Human Allogenic Neuronal Stem Cells and Mesenchymal Stem Cells for the Treatment of Parkinson Disease

PMC 2021 pmc.ncbi.nlm.nih.gov/articles/PMC8571682